Serum Lysozyme and Vitamin B12Binding Capacity in Myeloproliferative Disorders
- 1 December 1971
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 21 (6) , 661-672
- https://doi.org/10.1111/j.1365-2141.1971.tb02728.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A Diagnostic Test for Chronic Myelogenous Leukemia Based on Abnormalities of B12-bindingActa Medica Scandinavica, 2009
- Release of vitamin B12—binding protein by human leukocytes in vitroJournal of Clinical Investigation, 1970
- Experimental and Clinical Studies on Muramidase (Lysozyme)Acta Haematologica, 1970
- TRANSPORT OF VITAMIN B12 IN MANBritish Journal of Haematology, 1969
- MURAMIDASE ACTIVITY OF BONE MARROW PLASMAActa Medica Scandinavica, 1969
- The vitamin B12-binding protein in human leukocytesBiochimica et Biophysica Acta (BBA) - General Subjects, 1966
- Serum Lactic Dehydrogenase Activity and Folate Deficiency in Myelosclerosis and other Haematological DiseasesBMJ, 1966
- Investigations into the Euglena method for the assay of the vitamin B12 in serumJournal of Clinical Pathology, 1964
- Red‐Cell Production and Destruction in MyelosclerosisBritish Journal of Haematology, 1961
- Serum Vitamin B12Concentrations in Leukaemia and in some other Haematological ConditionsBritish Journal of Haematology, 1955